Home » Newsletters » BioWorld Science

BioWorld Science

May 30, 2002

View Archived Issues

Wyeth patents novel antiatherosclerotic agents

New analgesics in the Gruenenthal pipeline

Carbapenem antibiotics presented by Banyu

Toa Eiyo claims chymase inhibitors for use in hypertension and other disorders

Cell adhesion inhibitors and their use in asthma, inflammation, etc.

Nikken Chemicals patents TNF-alpha production inhibitors

Quinolines and isoquinolines identified as factor Xa inhibitors

Endostatin enters phase II trial in stage IV metastatic melanoma

Wilex and Aventis sponsor phase III trial in high-risk breast cancer

Preliminary data from human studies on gimatecan reported in Orlando

Opioid treatment of IBS associated with constipation provides symptom relief

ASCO presentation reports preliminary PK data and good tolerance for ILX-651

Dolastatin 10 assessed in phase II trial in advanced renal cell carcinoma at Mayo Clinic

Two different schedules of administration for AG-2037 under study in cancer patients

Preclinical and clinical results presented at major cancer meeting for SAHA, an HDAC inhibitor

Spotlight on topoisomerase inhibitors under development

AnorMED reviews fiscal 2002 and anticipates 2003 milestones

NP-1 enters phase II trials in neuropathic pain

Arena and Ferring collaborate on drug discovery in reproductive health

Novirio changes name to Idenix

NV-04 moves into clinical testing in cardiovascular disease

SIGA Technologies awarded SBIR grant for antibiotic development

IND filed for MDX-060

Genelabs expects Aslera NDA response by August 2002

Oncophage granted orphan drug status in renal cell carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...